Physician profile
Bruce Jay Levine
NPI 1063478196
$2,654.38
in general payments reported to CMS, 2019-2025
22 companies · $325 in 2025
The $325 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $754 · 2020: $156 · 2021: $316 · 2022: $198 · 2023: $305 · 2024: $600 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,229.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $631.31 | 2021-2025 | Augment Injectable, Citrefix, Iconix |
| Organogenesis INC. | $363.47 | 2019-2025 | Affinity, Apligraf, Via Matrix |
| Horizon Therapeutics Plc | $330.56 | 2019-2023 | Krystexxa |
| Wright Medical Technology, INC. | $326.04 | 2019-2020 | |
| Medtronic Vascular, INC. | $277.60 | 2019 | |
| Linvatec Corporation | $160.18 | 2023-2025 | Colink 2, Quantum, In2bones USA |
| Smith+Nephew, INC. | $121.48 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Regranex |
| Sebela Pharmaceuticals INC. | $65.41 | 2021-2023 | Naftin |
| Integra Lifesciences Corporation | $51.09 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bone Support INC. | $37.01 | 2024 | Ceramentbone Void Filler, Cerament G |
| Bioventus LLC | $36.63 | 2021 | |
| Alfasigma USA, INC. | $35.24 | 2021 | |
| Zyla Life Sciences, INC. | $29.48 | 2019 | |
| Treace Medical Concepts, INC. | $26.81 | 2024 | |
| Axogen | $24.63 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coastal Medical Technologies LLC | $23.02 | 2024 | |
| Kerecis Limited | $21.86 | 2021-2022 | |
| Abbott Laboratories | $21.51 | 2024 | Proclaim |
| Averitas Pharma INC. | $19.66 | 2024 | Qutenza |
| Orthofix Medical, INC. | $19.47 | 2024 | Physio-Stim |
| Sandoz INC. | $18.64 | 2019 | |
| Merck Sharp & Dohme LLC | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.